1 / 51

Neoplasms of Lung and Pleura

Neoplasms of Lung and Pleura. Dr. Raid Jastania. Lung Neoplasms. Neoplasm: new growth Monoclonal proliferation Genetic defect in genes controlling growth Oncogens, tumor suppressor genes, genes regulating apoptosis, DNA repair genes Benign and Malignant Features of malignancy

ranae
Download Presentation

Neoplasms of Lung and Pleura

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Neoplasms of Lung and Pleura Dr. Raid Jastania

  2. Lung Neoplasms • Neoplasm: • new growth • Monoclonal proliferation • Genetic defect in genes controlling growth • Oncogens, tumor suppressor genes, genes regulating apoptosis, DNA repair genes • Benign and Malignant • Features of malignancy • Anaplasia, invasion, rapid growth, metastasis

  3. Lung Neoplasm • Primary, Secondary • Benign, malignant • Primary neoplasms: • Arise from any cell type (epithelial, mesenchyml….) • 95% arise from bronchial epithelium (Bronchogenic carcinoma) • Others: neuroendocrine cells, mesenchymal cells

  4. Case

  5. Case

  6. What is the differential diagnoses of Mass lesion in the Lung

  7. Clinical Presentation • Mass lesion: incidental, asymptomatic, or causing mass effect • Dysfunction of the involved organ • Invasion of the adjacent structures • Metastasis • Paraneoplstic syndromes

  8. Hamartoma of lung • Not neoplastic, but mass lesion • Discrete small peripheral nodule seen incidentally on x-ray on chest • Benign, no risk of malignancy • Consists of mature tissue in abnormal, disordered organization: cartilage, fat, fibrous tissue, vessels….

  9. Bronchogenic Carcinoma • 1st cause of death due to Cancer • Increasing incidence in females • M:F ratio is 2:1, age 55-65 years • Strong relation to smoking • It is malignant neoplasm arising from the bronchial epithelium • Generally bad prognosis with high rate of mortality, 50% presents with metastasis, Overall survival is 14%

  10. Clinical Presentation • Commonly presents as lung mass with hilar lymphadenopathy, and symptoms related to lung disease • If localized: can be asymptomatic, or presents with persistent cough • Mass effect: resulting in respiratory dysfunction: cough, dyspnea, chest pain, hemoptysis • Invasion of Pleura resulting in pleural effusion or pleuritis. Invasion of mediastal structures and vessels • Mestastasis to brain, liver, adrenals….

  11. Clinical Presentation • Paraneoplastic Syndromes • Hypercalcemia due to PTH-related peptide • Cushing syndrome due to ACTH secretion • Syndrome of inappropriate ADH secretion SIADH • Neuromuscular syndrome: peripheral neuropathy, polymyositis • Clubbing of fingers • Thrombophlebitis, non-bacterial endocarditis, disseminated intravascular coagulation DIC

  12. Classification • Non-small cell lung cancer • Squamous cell carcinoma • Adenocarcinoma • Large cell undifferentiated carcinoma • Small cell lung cancer • Small cell carcinoma • Neuroendocrine tumors • Carcinoid • Atypical carcinoid • Small cell carcinoma

  13. Small cell carcinoma Most present with advance disease High grade with fast progression Associated with smoking (almost all) Treatment is palliative Respond to chemotherapy and radiation Non-small cell ca Can present with localized disease Variable behavior, depend on grade Sq ca is related to smoking, Adeno ca is less associated to smoking Treatment can be fro cure Surgery Value of the classification

  14. Etiology and Pathogenesis • Common gene defects in lung cancer • SCLC: P53, RB mutation • NSLC: P16/CDKN2A • Adenocarcinoma: K-RAS • Lung cancer develop through accumulation of genetic defects • Loss of 3p is very early event, occurs as a result of smoking

  15. Etiology and Pathogenesis • Smoking: • 90% of lung caner occurs in smokers • The risk shows linear increase with the smoking intensity (pack-years) • 60x risk in a person with 40 pack-years smoking • 2x risk in passive smokers • Others: asbestos, vinyl chloride… • Genetic susceptibility

  16. Etiology and Pathogenesis • Progression of lesions due to smoking: • Normal respiratory mucosa • Basal cell hyperplasia • Squamous metaplasia • Squamous dysplasia • Carcinoma in-situ • Invasive squamous cell carcinoma

  17. Morphology • Bronchial epithelium • Small mass arising from the bronchial epithelium • Invasion of submucosa and underlying lung tissue • Pushing and invasive borders • Central necrosis, hemorrhage, cavitation • Metastasis to lymph nodes: lobar, bronchial, hilar, mediastinal, cervical, supraclavicular • Hematogenous spread: brain, liver, adrenal, bone… • Body cavity metastasis: pleura

  18. Squamous cell carcinoma • M>F • Central mass, with areas of necrosis, and cavitation • Hilar lymphadenopathy • Distal obstruction, atelectasis • Malignant cells in sputum and bronchoalveolar lavage • Grade: well, moderate, poor differentiation • Paraneoplstic syndromes

  19. Adenocarcinoma • Less associated with smoking • Usually small, peripheral lung mass with gray gelatinous surface • Grade: well, moderate, poor differentiation • Metastasize early • Special pattern: bronchioloalveolar carcinoma BAC

  20. Large cell undifferentiated carcinoma • High grade tumor • Poorly differentiated

  21. Small cell carcinoma • Central mass with hilar and mediastinal lymphadopathy • Small cells, nuclear molding, fine chromatin, mitosis, necrosis, neuroendocrine features • High grade • Respond to chemotherapy and radiation

  22. Special presentation of lung cancer • Virchow node: supraclavicular node enlargement due to metastasis • Superior vena cava syndrome: obstruction of the SVC by cancer • Horner syndrome: ipsilateral enophthalmos, ptosis, meiosis, anhidrosis. It is caused by tumor involving the sympathetic nerves • Pancoast tumor: lung cancer involving the upper lobe.

  23. Carcinoid • Tumor arising from the endocrine cells (Kulchitsky cells) • Mean age 40 years • Good prognosis • Mass lesion: • Intraluminal mass in large bronchus • Peribronchial mass (collar-button lesion) • Metastasis: rare 5-15%

  24. Carcinoid • Micro: uniform cells with rounded nuclei, salt-and-pepper chromatin • Atypical carcinoid: if the tumor cells show mitosis and necrosis • 5 year survival: 50-95 %

  25. Malignant Mesothelioma • Arise from parietal or visceral pleura or peritoneum • 50% has relation to Asbestos, latent period 35-40 years • Pleural fibrosis – plaque – localized mass – mass encasing the lungs • Bad prognosis

  26. Diagnosis • Clinical presentation • Sputum • Pleural fluid • Fine needle aspiration • Biopsy • Resection

More Related